Compare REAL & SGRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | REAL | SGRY |
|---|---|---|
| Founded | 2011 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Specialty Stores | Hospital/Nursing Management |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 1.6B |
| IPO Year | 2019 | 2015 |
| Metric | REAL | SGRY |
|---|---|---|
| Price | $9.30 | $11.93 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 8 |
| Target Price | $17.00 | ★ $22.25 |
| AVG Volume (30 Days) | ★ 3.5M | 1.9M |
| Earning Date | 05-07-2026 | 03-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 43.55 | ★ 54.14 |
| EPS | N/A | ★ N/A |
| Revenue | $692,845,000.00 | ★ $1,145,438,000.00 |
| Revenue This Year | $14.30 | $5.09 |
| Revenue Next Year | $10.19 | $5.67 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 15.38 | N/A |
| 52 Week Low | $4.61 | $11.61 |
| 52 Week High | $17.39 | $24.60 |
| Indicator | REAL | SGRY |
|---|---|---|
| Relative Strength Index (RSI) | 34.66 | 31.46 |
| Support Level | $7.21 | N/A |
| Resistance Level | $11.48 | $16.15 |
| Average True Range (ATR) | 0.57 | 0.60 |
| MACD | -0.07 | -0.15 |
| Stochastic Oscillator | 19.06 | 10.53 |
The RealReal is the largest pure-play luxury resale platform in the US, generating $1.8 billion in 2024 gross merchandise volume and addressing a niche (personal luxury resale) that had previously been serviced by inefficient upscale boutiques and local pawn shops. The company generates revenue via consignment and first-party sales on its online marketplace, and through a small volume of direct sales. With a hands-on approach that actively sources inventory and authenticates every item on its platform, The RealReal is able to justify much higher take rates than peers, working out to roughly 36% of net merchandise value in 2024, which excludes returns, cancellations, and first-party sales.
Surgery Partners Inc is a healthcare services company with an integrated outpatient delivery model focused on providing quality, cost-effective solutions for surgical and related ancillary care in support of both patients and physicians. It has one reportable segment: Surgical Facilities, which includes the operation of ASCs, surgical hospitals, anesthesia services, and multi-specialty physician practices, which earn revenues from contracts with patients in which the performance obligations are to provide health care services.